PortfoliosStock ScreensStocksStockXcel

Bafna Pharmaceuticals Limited

BAFNAPH | NSE

111.32

INR

-0.64

-0.57%

BAFNAPH | NSE
Loading StockChartView...

About Bafna Pharmaceuticals Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

31/03/2024

As of date

02/04/2026

Close

111.32

Open

111.96

High

115.00

Low

109.55

View Less

BAFNAPH | NSE

Risk
62.9
Sharpe
0.73
Luna's Score
46/100
Recommendation
Hold

Luna says (BAFNAPH | NSE)

What's Working

Low Market Beta (-0.4 to 0.8)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

What's not Working

Price Below SMA10D

High Short-term Volatility

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

66.5%

1 month

62.9%

3 months

52.4%

6 months

48.5%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

674.92

Fwd. PE

-

Price to book

2.34

Debt to equity

0.30

Debt to assets

0.17

Ent. to EBITDA

14.27

Ent. to rev.

1.34

PEG

-

Other Fundamentals

EBITDA

57.11M

MarketCap

2.65B

MarketCap(USD)

28.48M

Div. yield

-

Op. margin

-0.70

Erngs. growth

-73.50

Rev. growth

-20.60

Ret. on equity

9.52

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

18.53

Range1M

31.75

Range3M

57.73

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.31

Price X volume

203.72K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Medicamen Biotech LimitedMEDICAMEQDrug Manufacturers-Specialty & Generic228.972.82B-1.15%82.7415.37%
Nectar Lifesciences LimitedNECLIFEDrug Manufacturers-Specialty & Generic10.042.28B2.87%138.0759.44%
Kilitch Drugs (India) LimitedKILITCHDrug Manufacturers-Specialty & Generic138.652.24B0.22%42.4417.95%
Lyka Labs LimitedLYKALABSBiotechnology55.531.98B8.52%813.9486.05%
Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSDrug Manufacturers-Specialty & Generic53.711.56B0.81%32.7523.61%
Brooks Laboratories LimitedBROOKSDrug Manufacturers-Specialty & Generic53.381.42B19.87%n/a8.60%
Alpa Laboratories LimitedALPADrug Manufacturers-Specialty & Generic51.751.09B3.07%13.543.45%
Bal Pharma LimitedBALPHARMADrug Manufacturers-Specialty & Generic65.41.05B0.82%25.83201.53%
Par Drugs And Chemicals LimitedPARDrug Manufacturers-Specialty & Generic82.471.03B-0.19%19.900.00%
Krebs Biochemicals & Industries LimitedKREBSBIODrug Manufacturers-Specialty & Generic47.631.02B7.18%n/a-162.25%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Madhav Copper LimitedMCLCopper60.361.67B4.99%82.2232.14%
Cubex Tubings LimitedCUBEXTUBCopper84.361.23B0.67%35.8521.78%
Touchwood Entertainment LimitedTOUCHWOODAdvertising Agencies66.71743.74M1.24%50.064.88%
Sagardeep Alloys LimitedSAGARDEEPCopper22.45389.73M-1.92%58.6243.14%
Heads UP Ventures LimitedHEADSUPApparel Retail6.97152.71M0.72%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA14.2724.85Cheaper
Ent. to Revenue1.3411.40Cheaper
PE Ratio674.9251.36Expensive
Price to Book2.346.83Cheaper
Dividend Yield-0.52-
Std. Deviation (3M)52.4342.17Riskier
Debt to Equity0.300.35Par
Debt to Assets0.170.17Par
Market Cap2.65B290.82BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007